Calendar AstraZeneca PLC Xetra

Equities

ZEG

GB0009895292

Market Closed - Xetra 09:05:31 07/06/2024 pm IST After market 01:00:02 am
148.2 EUR 0.00% Intraday chart for AstraZeneca PLC 148.6 +0.27%

Chart calendar AstraZeneca PLC

970cc8065836362de5.EQxvOke5pJlQ3HHev8Jobjr6BBNsLYdN6JtH_BGkpcc.YVUITBXj0fZjiT2x0PcGNBeqYSM7GMgLiep3jVr-zql2WApLHYv-yTS0PA~e03b8a4fc1620ef815531d6074a65b61

Upcoming events on AstraZeneca PLC

25/07/2024 11:30 am Q2 2024 Earnings Release
12/11/2024 12:30 pm Q3 2024 Earnings Release
06/02/2025 Q4 2024 Earnings Release (Projected)
25/04/2025 Q1 2025 Earnings Release (Projected)
24/07/2025 Q2 2025 Earnings Release (Projected)
06/11/2025 Q3 2025 Earnings Release (Projected)

Past events on AstraZeneca PLC

04/06/2024 06:00 am Investor Meeting
04/06/2024 01:42 am American Society of Clinical Oncology Meeting - Abstract No:LBA501
04/06/2024 12:00 am American Society of Clinical Oncology Meeting - Abstract No:8046
04/06/2024 12:00 am American Society of Clinical Oncology Meeting - Abstract No:8617
04/06/2024 12:00 am American Society of Clinical Oncology Meeting - Abstract No :8593
04/06/2024 12:00 am American Society of Clinical Oncology Meeting - Abstract No:8623
04/06/2024 12:00 am American Society of Clinical Oncology Meeting - Abstract No :8548
04/06/2024 12:00 am American Society of Clinical Oncology Meeting - Abstract No :8543
03/06/2024 09:21 pm American Society of Clinical Oncology Meeting - Abstract No:4019
03/06/2024 07:42 pm American Society of Clinical Oncology Meeting - Abstract No:8005
03/06/2024 03:06 am American Society of Clinical Oncology Meeting - Abstract No:8011
03/06/2024 02:54 am American Society of Clinical Oncology Meeting - Abstract No:1006
03/06/2024 01:51 am American Society of Clinical Oncology Meeting - Abstract No:LBA5
03/06/2024 01:17 am American Society of Clinical Oncology Meeting - Abstract No:LBA4
02/06/2024 07:30 pm American Society of Clinical Oncology Meeting - Abstract No:1025
02/06/2024 06:00 pm American Society of Clinical Oncology Meeting - Abstract No:LBA1000
02/06/2024 03:54 am American Society of Clinical Oncology Meeting - Abstract No:1009
02/06/2024 12:09 am American Society of Clinical Oncology Meeting - Abstract No:5510
02/06/2024 12:00 am American Society of Clinical Oncology Meeting - Abstract No:TPS4182
02/06/2024 12:00 am American Society of Clinical Oncology Meeting - Abstract No:TPS4187

Past dividends on AstraZeneca PLC

22/02/2024 Final Payment 1.56 GBP
10/08/2023 Interim Payment 0.718 GBP
23/02/2023 Final Payment 1.628 GBP
11/08/2022 Interim Payment 0.764 GBP
24/02/2022 Final Payment 1.453 GBP
12/08/2021 Interim Payment 0.648 GBP
25/02/2021 Final Payment 1.374 GBP
13/08/2020 Interim Payment 0.696 GBP
27/02/2020 Final Payment 1.464 GBP
08/08/2019 Interim Payment 0.719 GBP

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
24 384
24 440
-0.23%
26 617
26 378
0.91%
37 417
36 239
3.25%
44 351
44 465
-0.26%
45 811
45 716
0.21%

51 620

EBITDA
Million USD
Released
Forecast
Spread
6 686
6 882
-2.84%
8 311
8 087
2.76%
7 586
10 816
-29.87%
9 237
13 681
-32.49%
13 580
15 477
-12.26%

17 920

EBIT
Million USD
Released
Forecast
Spread
6 436
6 631
-2.95%
7 340
7 417
-1.04%
9 928
10 003
-0.75%
13 350
13 702
-2.57%
14 534
15 036
-3.34%

16 821

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
1 548
2 130
-27.34%
3 916
4 387
-10.74%
-265
1 510
-117.55%
2 501
3 511
-28.78%
6 899
9 269
-25.57%

11 091

Net income
Million USD
Released
Forecast
Spread
1 335
1 895
-29.55%
3 196
2 930
9.09%
112
2 055
-94.55%
3 288
4 262
-22.86%
5 961
6 597
-9.64%

8 844

EPS
USD
Released
Forecast
Spread
1,03
1,41
-26.77%
2,44
2,50
-2.26%
0,08
1,99
-95.98%
2,11
2,81
-24.96%
3,81
4,34
-12.22%

5,67

Announcement Date14/02/2011/02/2110/02/2209/02/2308/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD
Released
Forecast
Spread
11 390
10 967
3.86%
10 771
10 577
1.83%
10 982
10 848
1.23%
11 207
11 287
-0.71%
10 879
10 559
3.03%
11 416
11 018
3.62%
11 492
11 529
-0.32%
12 024
12 007
0.14%
12 679
11 812
7.34%

12 574


12 972


13 475


13 410


13 730

EBITDA
Million USD
Released
Forecast
Spread
2 187
3 894
-43.83%
1 896
5 337
-64.47%
2 579
2 556
0.88%
2 574
2 966
-13.22%



3 732
4 074
-8.39%










4 396


4 404


5 260







EBIT
Million USD
Released
Forecast
Spread
3 961
3 486
13.62%
3 365
3 291
2.25%
3 413
3 189
7.03%
2 610
2 916
-10.5%
3 946
3 517
12.21%
4 291
4 005
7.13%
3 545
3 537
0.24%
2 752
3 206
-14.15%
4 310
3 911
10.2%

4 027


4 356


3 974







Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
553
972
-43.08%
247
580
-57.38%
922
1 007
-8.4%
778
806
-3.47%
2 262
1 834
23.34%
2 088
2 410
-13.36%
1 652
2 510
-34.17%
897
1 671
-46.32%
2 800
2 296
21.95%

2 361


2 740


3 099







Net income
Million USD
Released
Forecast
Spread
386
1 086
-64.45%
360
946
-61.96%
1 640
895
83.16%
901
2 096
-57.02%
1 803
1 594
13.14%
1 818
2 123
-14.37%
1 378
1 705
-19.16%
959
2 313
-58.53%
2 179
2 065
5.52%

2 092


2 450


2 493







EPS
USD
Released
Forecast
Spread
0,25
0,70
-64.25%
0,23
0,78
-70.61%
1,05
0,58
82.48%
0,58
1,35
-57.11%
1,16
1,08
7.44%
1,17
1,36
-14.03%
0,89
1,09
-18.64%
0,62
1,49
-58.3%
1,41
1,33
6.28%

1,34


1,57


1,60







Announcement Date29/04/2229/07/2210/11/2209/02/2327/04/2328/07/2309/11/2308/02/2425/04/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise